Branebrutinib
≥99%
- Product Code: 99867
CAS:
1912445-55-6
| Molecular Weight: | 370.42 g./mol | Molecular Formula: | C₂₀H₂₃FN₄O₂ |
|---|---|---|---|
| EC Number: | MDL Number: | ||
| Melting Point: | Boiling Point: | ||
| Density: | Storage Condition: | 2-8℃ |
Product Description:
Branebrutinib is primarily used in the treatment of autoimmune diseases, particularly those involving B-cell signaling pathways. It functions as a Bruton's tyrosine kinase (BTK) inhibitor, which helps in modulating the immune response by targeting specific pathways involved in inflammation and autoimmunity. This makes it effective in conditions like rheumatoid arthritis, lupus, and other systemic autoimmune disorders. Additionally, it is being explored for its potential in treating certain types of cancers, especially those driven by B-cell malignancies, due to its ability to inhibit BTK, a key player in B-cell proliferation and survival. Its targeted mechanism offers a more precise approach compared to traditional immunosuppressive therapies, potentially reducing side effects while improving efficacy.
Sizes / Availability / Pricing:
| Size (g) | Availability | Price | Quantity |
|---|---|---|---|
| 0.005 | 10-20 days | ฿13,086.00 |
+
-
|
| 0.010 | 10-20 days | ฿20,817.00 |
+
-
|
Branebrutinib
Branebrutinib is primarily used in the treatment of autoimmune diseases, particularly those involving B-cell signaling pathways. It functions as a Bruton's tyrosine kinase (BTK) inhibitor, which helps in modulating the immune response by targeting specific pathways involved in inflammation and autoimmunity. This makes it effective in conditions like rheumatoid arthritis, lupus, and other systemic autoimmune disorders. Additionally, it is being explored for its potential in treating certain types of cancers, especially those driven by B-cell malignancies, due to its ability to inhibit BTK, a key player in B-cell proliferation and survival. Its targeted mechanism offers a more precise approach compared to traditional immunosuppressive therapies, potentially reducing side effects while improving efficacy.
| Mechanism | - |
| Appearance | - |
| Longevity | - |
| Strength | - |
| Storage | - |
| Shelf Life | - |
| Allergen(s) | - |
| Dosage (Range) | - |
| Recommended Dosage | - |
| Dosage (Per Day) | - |
| Recommended Dosage (Per Day) | - |
| Mix Method | - |
| Heat Resistance | - |
| Stable in pH range | - |
| Solubility | - |
| Product Types | - |
| INCI | - |
Cart
No products
Subtotal:
฿0.00
฿0.00
Total :